0001225208-17-009512.txt : 20170511 0001225208-17-009512.hdr.sgml : 20170511 20170511170546 ACCESSION NUMBER: 0001225208-17-009512 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170510 FILED AS OF DATE: 20170511 DATE AS OF CHANGE: 20170511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COLGATE PALMOLIVE CO CENTRAL INDEX KEY: 0000021665 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 131815595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2123102000 MAIL ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HUSTON JOHN J CENTRAL INDEX KEY: 0001227249 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-00644 FILM NUMBER: 17835290 MAIL ADDRESS: STREET 1: C/O COLGATE PALMOLIVE CO STREET 2: 300 PARK AVE 15TH FL CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml X0306 4 2017-05-10 0000021665 COLGATE PALMOLIVE CO CL 0001227249 HUSTON JOHN J C/O COLGATE-PALMOLIVE COMPANY 300 PARK AVENUE NEW YORK NY 10022 1 SVP, Chief of Staff Common Stock 2017-05-10 4 M 0 14000.0000 45.2300 A 102838.0000 D Common Stock 2017-05-10 4 S 0 14000.0000 71.5251 D 88838.0000 D Common Stock 2055.0000 I By children Common Stock 36087.0000 I By Issuer's 401(k) Plan Trustee Stock Option (Right to Buy) 45.2300 2017-05-10 4 M 0 14000.0000 0.0000 D 2017-09-08 Common Stock 14000.0000 14000.0000 D Exercise of stock options awarded under the issuer's employee stock option plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's employee stock option plan and the related tax withholding. This transaction was effected pursuant to a Rule 10b5-1 trading plan. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $71.27 to $71.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Option became exercisable in one-third increments beginning on the first anniversary of the September 8, 2011 grant date. /s/ Kristine Hutchinson, Attorney-in-Fact 2017-05-11